Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

53 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Correction to "Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo".
Comert Onder F, Kahraman N, Bellur Atici E, Cagir A, Kandemir H, Tatar G, Taskin Tok T, Kara G, Karliga B, Durdagi S, Ay M, Ozpolat B. Comert Onder F, et al. Among authors: kara g. ACS Pharmacol Transl Sci. 2021 May 4;4(3):1247. doi: 10.1021/acsptsci.1c00113. eCollection 2021 Jun 11. ACS Pharmacol Transl Sci. 2021. PMID: 34151214 Free PMC article.
Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo.
Comert Onder F, Kahraman N, Bellur Atici E, Cagir A, Kandemir H, Tatar G, Taskin Tok T, Kara G, Karliga B, Durdagi S, Ay M, Ozpolat B. Comert Onder F, et al. Among authors: kara g. ACS Pharmacol Transl Sci. 2021 Mar 30;4(2):926-940. doi: 10.1021/acsptsci.1c00030. eCollection 2021 Apr 9. ACS Pharmacol Transl Sci. 2021. PMID: 33860211
53 results